Bioorgánica
BIOORG
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (8)
2024
2023
-
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma
Pharmaceutics, Vol. 15, Núm. 1
-
Small molecule anion carriers facilitate lactate transport in model liposomes and cells
iScience, Vol. 26, Núm. 10
2022
2019
-
Targeting autophagy for cancer treatment and tumor chemosensitization
Cancers, Vol. 11, Núm. 10
-
The natural-based antitumor compound T21 decreases survivin levels through potent stat3 inhibition in lung cancer models
Biomolecules, Vol. 9, Núm. 8
-
Therapeutic strategies involving survivin inhibition in cancer
Medicinal Research Reviews, Vol. 39, Núm. 3, pp. 887-909
2017
-
Novel indole-based tambjamine-analogues induce apoptotic lung cancer cell death through p38 mitogen-activated protein kinase activation
Molecular Cancer Therapeutics, Vol. 16, Núm. 7, pp. 1224-1235